Chicago Cubs exec possibly tips hand at GM meetings regarding Shota Imanaga ploy
Could the Chicago Cubs be playing a game of high-stakes chess when it comes to pitcher Shota Imanaga? It’s certainly looking that way.
More News: Chicago Cubs: Dodgers possibly souring on Kyle Tucker, Cubs remain long shot suitors
Early last week, the Cubs made headlines when they declined their team option on the lefty starter, which would’ve activated a 3-year, $57 million extension. In turn, the Japanese star would decline his $15 million player option. The mutual rejections made Imanaga a free agent.
But then the Cubs made him a qualifying offer of just over $22 million for 2026.
Contractual chess by the Chicago Cubs

More News: Why the Chicago Cubs need to stay far away from incoming Japanese free agent star
The move was of multiple possible benefit to Chicago. First, it guaranteed them draft pick compensation should Imanaga be signed by another team. Second, it made the 2024 Rookie of the Year candidate a somewhat less attractive free agent target, thereby facilitating a possible return to the Cubs on a more club-favorable contract. Finally, if all else failed and Imanaga signed elsewhere, the Cubs would be pruning a good chunk of their payroll and (hopefully) putting that money towards the acquisition of a front-of-rotation starter.
Imanaga’s situation, however, is not as win-win as the Cubs’.
The 32-year-old is coming off a rough 2025, where a hamstring injury hobbled the first half of the season and inconsistency (via the long ball) plagued the second half. His bad September (6.51 ERA) would spill over to the playoffs, where he posted an 8.10 ERA in two starts before falling completely outside the circle of confidence of manager Craig Counsell.
The feeling is that Imanaga may have some trouble getting a multi-year contract from another team as his performance trends deeply downward and the feeling begins to emerge that the league may have caught up with the tricky southpaw.
The value of Shota Imanaga

Still, there’s value in Imanaga. He IS just one year removed from being an elite-tier starting pitcher and he did post a 3.73 ERA last season despite his propensity for giving up home runs. Even at his very worst, he’s a thoughtful, cerebral competitor who has shown the ability to adjust his way out of trouble.
Although the Cubs balked at the 3-year extension, which would’ve given him just over $19 million a year, they’re still talking as though they would have him back. The feeling may be that his contractual worth is significantly lower as he settles into a more realistic spot as a middle-of-rotation or back-of-rotation starter.
“We obviously value Shota a ton,” Cubs president of baseball operations Jed Hoyer told the Marquee Sports Network at this week’s GM meetings in Las Vegas. “I think he was amazing for us as a pitcher, as a teammate and, you know, I don’t want to close that door completely by any stretch. But ultimately, we didn’t think that the club option was the right value, he didn’t think that the player option was the right value and, you know, that happen
“Clearly, we made him a qualifying offer and there’s nothing that prohibits us from still talking to him. So, I don’t want to close that door, but obviously, like I said, the way that we valued the club option, the way he valued the player option, [we] obviously we didn’t meet up there.”
A reunion is still very possible

The thought among many analysts is that Hoyer and the Cubs are gambling on Imanaga eventually coming back to the table where both sides can hammer out a more team-friendly deal, perhaps one for just two years sporting a lower base pay, but with incentives beefing up the pitcher’s potential earnings.
“You want to make sure nothing is lost in translation,” Hoyer told The Athletic. “But it’s a complicated structure. And with that structure, ultimately, we felt like it wasn’t the right thing to do to pick up the club option. He very quickly felt like it wasn’t the right thing to do with the player option. There’s no hard feelings on either side.
“We just move forward. We each had a specific number, and I think he understands that. My dialogue with them has been really good. Bad blood or anything like that, that’s not something I worry about.”
Jon Heyman, MLB insider for the New York Post, is reporting that Imanaga “is expected to decline the [Cubs’] $22M qualifying offer.” If accurate, this wouldn’t be a major surprise and it also wouldn’t necessarily eliminate the possibility of a reunion with the Cubs.
Imanaga has until November 18 to decide on Chicago’s qualifying offer.
The post Chicago Cubs exec possibly tips hand at GM meetings regarding Shota Imanaga ploy appeared first on ChiCitySports.
Source: https://www.chicitysports.com/chicago-cubs-shota-imanaga-hoyer-gm-meetings
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.

